Updated: February 5, 2026
Tiagabine Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
- Is Tiagabine in an FDA-Declared Shortage in 2026?
- Why Tiagabine Feels Hard to Find (Even Without a Formal Shortage)
- Has Tiagabine Ever Been in a Formal Shortage?
- What Patients Should Watch For
- Why Epilepsy Patients Cannot Afford Supply Interruptions
- What to Do Right Now If You're Having Trouble
- The Bottom Line for Tiagabine Patients in 2026
Is tiagabine in shortage in 2026? Here's the latest availability update, why some patients still struggle to fill it, and what you can do right now.
If you take tiagabine (Gabitril) to manage partial seizures, you may have heard concerns about availability or experienced trouble filling your prescription. This guide provides the most up-to-date picture of tiagabine availability in 2026 and what you should know as a patient.
Is Tiagabine in an FDA-Declared Shortage in 2026?
As of 2026, tiagabine is not on the FDA's official drug shortage list. The FDA Drug Shortages database tracks medications with formal supply interruptions reported by manufacturers. Tiagabine's absence from the list means there is no widespread, manufacturer-reported supply crisis.
However, "not in formal shortage" doesn't mean "easy to find." Many patients still encounter real difficulty locating tiagabine at their local pharmacy, and understanding why can help you take the right steps.
Why Tiagabine Feels Hard to Find (Even Without a Formal Shortage)
Tiagabine is a second-line or adjunctive antiepileptic drug — it's added to other seizure medications when those medications alone don't fully control partial seizures. This means it's prescribed to a relatively small number of patients compared to first-line drugs like levetiracetam or lamotrigine.
Pharmacies stock medications based on local demand. If your pharmacy doesn't fill many tiagabine prescriptions, they may not keep it on their regular inventory — even when the drug is technically available from wholesalers. This creates what's sometimes called a "local shortage" or availability gap that is real to the patient even if not reflected in official data.
Has Tiagabine Ever Been in a Formal Shortage?
Tiagabine has not been the subject of a high-profile, sustained national shortage like those seen with stimulants (Adderall), weight-loss drugs (semaglutide), or certain ADHD medications. The drug has been available in the US since 1997 and generic versions have been marketed for years, giving the supply chain more resilience than brand-only or newly approved drugs.
What Patients Should Watch For
Even without a formal shortage, tiagabine patients should be alert to these warning signs that availability may be tightening at their pharmacy:
Your pharmacy says they've had to wait longer than usual for wholesaler deliveries
Multiple pharmacies in your area are out of stock simultaneously
Your pharmacy is substituting a different dosage strength due to lack of your usual strength
You're being told tiagabine is backordered from the wholesaler
If you notice any of these signs, contact your neurologist promptly so they can help plan ahead.
Why Epilepsy Patients Cannot Afford Supply Interruptions
Unlike many medications, you cannot simply skip a few days of tiagabine and pick up where you left off. Stopping tiagabine abruptly or having even short gaps in therapy can:
Trigger rebound seizures — often more severe than your baseline
Cause status epilepticus — a dangerous prolonged seizure requiring emergency treatment
Jeopardize your driving privileges (many states require a seizure-free period)
Impact your work, safety, and daily life
What to Do Right Now If You're Having Trouble
If you're currently struggling to fill tiagabine, here are immediate steps:
Don't wait until you're out. Contact your pharmacy as soon as your prescription becomes eligible for refill.
Use medfinder to find pharmacies near you that have tiagabine in stock — without spending your day on the phone.
Ask your pharmacy to special-order your next fill so it arrives before you run out.
Talk to your neurologist about transitioning to mail-order pharmacy for more reliable supply.
If supply problems are persistent, discuss whether an alternative anticonvulsant might be appropriate for your situation.
The Bottom Line for Tiagabine Patients in 2026
Tiagabine is not in a formal FDA shortage in 2026, but localized pharmacy availability can still be a real problem for individual patients. Plan ahead, refill early, and use resources like medfinder to locate your medication without delay. If you've had repeated trouble finding tiagabine, talk to your neurologist — see our guide on alternatives to tiagabine for what other options may be available.
Frequently Asked Questions
As of 2026, tiagabine is not listed on the FDA's official drug shortage database. However, some patients still experience difficulty filling prescriptions locally because many pharmacies don't routinely stock this niche anticonvulsant. This is a stocking issue, not a formal supply crisis.
Call multiple pharmacies, ask your pharmacy to place a special order (typically 1-3 business days), or use medfinder to locate a pharmacy with tiagabine in stock near you. Never stop tiagabine abruptly — contact your neurologist if you're at risk of running out.
No. Skipping doses or abruptly stopping tiagabine can trigger rebound seizures or status epilepticus, which is a medical emergency. If you are at risk of missing doses, contact your neurologist or go to urgent care immediately.
Tiagabine (Gabitril) was FDA-approved in 1997 and has been available in the US for nearly three decades. Generic versions have been available for years. Despite its long history, it remains a niche medication prescribed to a relatively small number of patients.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Tiagabine also looked for:
More about Tiagabine
36,837 have already found their meds with Medfinder.
Start your search today.





